Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.

[1]  E. Hannan,et al.  Everolimus-eluting stents or bypass surgery for multivessel coronary disease. , 2015, The New England journal of medicine.

[2]  A. Yeung,et al.  Trial of everolimus-eluting stents or bypass surgery for coronary disease. , 2015, The New England journal of medicine.

[3]  P. Kolh,et al.  2014 ESC/EACTS guidelines on myocardial revascularization. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[4]  J. Tu,et al.  Clinical Outcomes of Treatment by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients With Chronic Kidney Disease Undergoing Index Revascularization in Ontario , 2014, Circulation. Cardiovascular interventions.

[5]  A. Go,et al.  Acute kidney injury after CABG versus PCI: an observational study using 2 cohorts. , 2014, Journal of the American College of Cardiology.

[6]  Takeshi Kimura,et al.  Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). , 2014, The American journal of cardiology.

[7]  G. Stone,et al.  Coronary artery calcification: pathogenesis and prognostic implications. , 2014, Journal of the American College of Cardiology.

[8]  Mario Fusaro,et al.  Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis , 2013, BMJ.

[9]  C. Herzog,et al.  Long-Term Survival and Repeat Coronary Revascularization in Dialysis Patients After Surgical and Percutaneous Coronary Revascularization With Drug-Eluting and Bare Metal Stents in the United States , 2013, Circulation.

[10]  P. Serruys,et al.  Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents: A Prospective Cohort Study , 2012, Circulation.

[11]  B. Gersh.  Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial , 2012 .

[12]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[13]  Antonio Colombo,et al.  Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. , 2011, European heart journal.

[14]  A. Jeremias,et al.  CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING THE XIENCE V® EVEROLIMUS-ELUTING STENT PRESENTING WITH CHRONIC KIDNEY DISEASE: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY , 2011 .

[15]  E. Edelman,et al.  Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings , 2011, Circulation.

[16]  D. Faxon,et al.  Percutaneous coronary intervention of moderate to severe calcified coronary lesions: Insights from the National Heart, Lung, and Blood Institute Dynamic Registry , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  K. Harjai,et al.  Drug-Eluting Stents in Patients with Chronic Kidney Disease: A Prospective Registry Study , 2010, PloS one.

[18]  Taira Kobayashi,et al.  Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. , 2010, The Annals of thoracic surgery.

[19]  M. Mack,et al.  THE IMPACT OF RENAL INSUFFICIENCY ON 2-YEAR OUTCOMES FOLLOWING PCI OR CABG IN THE SYNTAX TRIAL , 2010 .

[20]  M. Nakano,et al.  Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  G. Athappan,et al.  Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature. , 2009, Minerva cardioangiologica.

[22]  I. Komuro,et al.  Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[23]  D. Charytan,et al.  The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. , 2006, Kidney international.

[24]  W. Laskey,et al.  Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. , 2006, The Journal of invasive cardiology.

[25]  S. Steinhubl,et al.  Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. , 2006, The Journal of invasive cardiology.

[26]  M. Gheorghiade,et al.  Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. , 2006, European heart journal.

[27]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[28]  C. Gullion,et al.  Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. , 2004, Archives of internal medicine.

[29]  D. Rubin.  Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation , 2001, Health Services and Outcomes Research Methodology.

[30]  A. Collins,et al.  Chronic kidney disease and cardiovascular disease in the Medicare population. , 2003, Kidney international. Supplement.

[31]  Robert M Califf,et al.  Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. , 2003, Journal of the American Society of Nephrology : JASN.

[32]  M. Bell,et al.  The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. , 2002, Journal of the American College of Cardiology.

[33]  N. Weissman,et al.  Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency. , 2002, The American journal of cardiology.

[34]  P D Cleary,et al.  Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. , 2001, Journal of clinical epidemiology.

[35]  I. Palacios,et al.  Are Patients With Renal Failure Good Candidates for Percutaneous Coronary Revascularization in the New Device Era? , 2000, Circulation.

[36]  D. Baim,et al.  Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. , 2000, The American journal of cardiology.

[37]  E. Hannan,et al.  A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. , 1999, Journal of the American College of Cardiology.

[38]  A. Collins,et al.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. , 1998, The New England journal of medicine.

[39]  D. Baim,et al.  Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. , 1994, American heart journal.

[40]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .